A framework for stakeholder engagement in the adoption of new anti-malarial treatments in Africa:

Simple item page
dc.contributor.authorMokuolu, Olugbenga Ayodeji
dc.contributor.authorBolarinwa,Oladimeji Akeem
dc.contributor.authorOpadiran, Oluwatumobi Racheal
dc.contributor.authorAmeen, Hafsat Abolore
dc.contributor.authorDhorda, Mehul
dc.contributor.authorCheah, Phaik Yeong
dc.contributor.authorAmaratunga,Chanaki
dc.contributor.authorde Haan, Freek
dc.contributor.authorTindana,Paulina
dc.contributor.authorDondorp,Arjen M.
dc.date.accessioned2025-04-17T08:43:25Z
dc.date.available2025-04-17T08:43:25Z
dc.date.issued2023
dc.description.abstractBackground Recent reports of artemisinin partial resistance from Rwanda and Uganda are worrisome and suggest a future policy change to adopt new anti-malarials. This is a case study on the evolution, adoption, and implementation of new anti-malarial treatment policies in Nigeria. The main objective is to provide perspectives to enhance the future uptake of new anti-malarials, with an emphasis on stakeholder engagement strategies. Methods This case study is based on an analysis of policy documents and stakeholders’ perspectives drawn from an empirical study conducted in Nigeria, 2019–2020. A mixed methods approach was adopted, including historical accounts, review of programme and policy documents, and 33 qualitative in-depth interviews and 6 focus group discussions. Results Based on policy documents reviewed, the adoption of artemisinin-based combination therapy (ACT) in Nigeria was swift due to political will, funding and support from global developmental partners. However, the implementation of ACT was met with resistance from suppliers, distributors, prescribers, and end-users, attributed to market dynamics, costs and inadequate stakeholder engagement. Deployment of ACT in Nigeria witnessed increased developmental partner support, robust data generation, ACT case-management strengthening and evidence on anti malarial use in severe malaria and antenatal care management. A framework for efective stakeholder engagement for the future adoption of new anti-malarial treatment strategies was proposed. The framework covers the pathway from generating evidence on drug efcacy, safety and uptake; to making treatment accessible and afordable to end-users. It addresses which stakeholders to engage with and the content of engagement strategies with key stakeholders at diferent levels of the transition process. Conclusion Early and staged engagement of stakeholders from global bodies to community level end-users is critical to the successful adoption and uptake of new anti-malarial treatment policies. A framework for these engage ments was proposed as a contribution to enhancing the uptake of future anti-malarial strategies.
dc.identifier.urihttps://uilspace.unilorin.edu.ng/handle/123456789/15083
dc.language.isoen
dc.publisherMalaria Journal
dc.relation.ispartofseriesVol,22(185); 1-13
dc.subjectArtemisinin resistance
dc.subjectStakeholder engagement
dc.subjectArtemisinin-based combination therapy
dc.subjectFramework
dc.subjectAntimalarial treatment policy
dc.titleA framework for stakeholder engagement in the adoption of new anti-malarial treatments in Africa:
dc.title.alternativeA case study of Nigeria
dc.typeArticle

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
P28_Stakeholder engaement Malaria.pdf
Size:
1.21 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections